News Summary
PositiveRevvity delivered a strong Q3 2026 earnings beat (EPS $1.37 vs. $1.30 consensus, revenue $729M vs. expectations) and raised FY2026 guidance to $5.40–$5.45, prompting multiple price-target increases from major banks. The company is advancing its AI-enabled lab software platform (Signals LabGistics) and will outline long-term strategy at an Investor Day on November 13, 2026.
Red flags
- •Valuation concern: GuruFocus indicates stock is ~35% overvalued at $161 vs. GF Value of $120
- •Analyst ratings remain neutral: despite price-target raises, TD Cowen, Barclays, BofA, and J.P. Morgan all maintain Hold/Equal-Weight ratings, suggesting limited upside conviction
- •Post-earnings selling pressure: stock fell 3.36% after initial +7.84% pop, signaling weak near-term technicals despite solid fundamentals
- •Insider selling activity: VP/CAO sold 84 shares on October 1, 2026 (minor but noted)
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Durable Capital Partners | Henry Ellenbogen | 1.3M | +1.3M | $202M | 2.1% | — | NEW |
| Glenview Capital | Larry Robbins | 6K | +6K | $1M | <0.1% | — | NEW |
| Maverick Capital | Lee Ainslie | 2K | +2K | $0M | <0.1% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where RVTY ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #17 of this fund's book
- 14CRH PLC$244M
- 15PRIVIA HEALTH GROUP INC$236M
- 16CLEAN HARBORS INC$226M
- 17REVVITY INC$202M
- 18UL SOLUTIONS INC$190M
- 19FLOWSERVE CORP$189M
- 20MEDLINE INC$164M
Values are quarter-end position sizes. Shown only for funds where RVTY ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Gonzales Anita | VP and CAO | SELL | 84 | $155.48 | $0.01M | 2026-10-01 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| EdgePoint Investment Group Inc. | SC 13G/A | 5.3M | 4.8% | 2026-11-16 | ↗ |
| JANUS HENDERSON GROUP Ltd. | SC 13G/A | 7.4M | 6.6% | 2026-11-16 | ↗ |
| T. Rowe Price Associates, Inc. | SC 13G/A | 13.2M | 11.8% | 2026-10-07 | ↗ |
| T. Rowe Price Investment Management, Inc. | SC 13G/A | 10.3M | 9.2% | 2026-09-08 | ↗ |
| T. Rowe Price Investment Management, Inc. | SC 13G/A | 18.3M | 16.4% | 2026-08-14 | ↗ |
| T. Rowe Price Associates, Inc. | SC 13G/A | 5.5M | 5.0% | 2026-08-14 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.